Long term effect of medroxyprogesterone acetate in human ovarian morphophysiology and sperm transport.
D000328:Adult; D001706:Biopsy; D050260:Carbohydrate Metabolism; D003238:Connective Tissue / Q000473:pathology; D003270:Contraceptive Agents / Q000008:administration & dosage / Q000494:pharmacology*; D003338:Corpus Luteum / Q000254:growth & development; D005187:Fallopian Tubes / Q000187:drug effects; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D006801:Humans; D007273:Injections, Intramuscular; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D007813:Laparotomy; D007986:Luteinizing Hormone / Q000378:metabolism; D008297:Male; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000494:pharmacology*; D008875:Middle Aged; D010049:Ovarian Diseases / Q000139:chemically induced; D006080:Ovarian Follicle / Q000254:growth & development; D010053:Ovary / Q000187:drug effects* / Q000201:enzymology; D010060:Ovulation / Q000187:drug effects*; D010088:Oxidoreductases / Q000652:urine; D011247:Pregnancy; D011276:Pregnanediol / Q000652:urine; D013094:Spermatozoa / Q000187:drug effects* / Q000502:physiology; D013194:Staining and Labeling; D013385:Succinate Dehydrogenase / Q000378:metabolism; D013997:Time Factors; D014599:Uterus / Q000187:drug effects
D003270:Contraceptive Agents; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D010088:Oxidoreductases; D007770:L-Lactate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D013385:Succinate Dehydrogenase; D008525:Medroxyprogesterone; D011276:Pregnanediol